Gilead Sciences reported $4.37B in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
ALKERMES ALKS:US $ -0.27M 23.16M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amgen AMGN:US $ 3228M 40M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Bristol Myers Squibb BMY:US $ 5712M 33M
Coherus Biosciences CHRS:US $ -31.9M 8.61M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Gilead Sciences GILD:US $ 4370M 1605M
Glaxosmithkline GSK:US $ 3660M 1034M
GlaxoSmithKline GSK:LN 3660M 1034M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Johnson & Johnson JNJ:US $ 8192M 2043M
Moderna Inc MRNA:US 3.63B 497M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Novartis NOVN:VX SF 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M
United Therapeutics UTHR:US $ 242.3M 7.7M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
YTE INCY:US $ 262.16M 92.39M